Loading…
India Infra Updates on WhatsApp
Join the Tenderkart WhatsApp channel for India Infra Updates
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹3,015 |
| 2 | Schedule 2 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹9,597.60 |
| 3 | Schedule 3 | KUMAR AND BROTHERSLikely | RA Ended | 1 | ₹20,716.50 |
| 4 | Schedule 4 | AMAR MEDICOLikely | RA Ended | 1 | ₹4,059 |
| 5 | Schedule 5 | AMAR MEDICOLikely | RA Ended | 1 | ₹2,520 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
16 May 2024, 8:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
AMOXYCILLIN 125 MG DISPERSIBLE TAB (Q3)
Apalutamide 240mg (Q3)
Apramilast 30 Mg Tab (Q3)
Aripiprazole 10 mg Tab (Q3)
Aripiprazole 15 mg Tab (Q3)
Beclometasone (0.025% w/v) + Clotrimazole (1% w/v) lotion 15 m (Q3)
BECLOMETHASONE DIPROPIONATE 0.05% LOTION (Q3)
CARBIDOPA 10 MG+ LEVODOPA 100 MG CR TAB (Q3)
CARBIDOPA 18.75+ LEVODOPA 75 MG+ ENTACAPONE 200 MG TAB (Q3)
CARBIDOPA 25 MG+ LEVODOPA 100 MG CR TAB (Q3)
Chlordiazepoxide 10mg Tab (Q3)
CLOBAZAM 10 MG TAB (Q3)
CLOBETASOL+ NEOMYCIN (PROPYGENTA) CREAM (Q3)
Danazol 200 mg Tab (Q3)
DANAZOL 50MG TAB (Q3)
Dorzolamide 2% w/v+ Timolol 0.5% w/v E/D (Q3)
E/D Brinzolamide 1% (Q3)
6306029
GEM/2024/B/4855748
Two Packet Bid
AMOXYCILLIN 125 MG DISPERSIBLE TAB,Apalutamide 240mg,Apramilast 30 Mg Tab,Aripiprazole 10 mg Tab,Ar
30 days
Punjab; Amritsar
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery | Spec |
|---|---|---|---|---|
| AMOXYCILLIN 125 MG DISPERSIBLE TAB (Q3) | AMRITSAR | 1,500 | 30 days | |
| Apalutamide 240mg (Q3) | AMRITSAR | 90 | 30 days | |
| Apramilast 30 Mg Tab (Q3) | AMRITSAR | 1,050 | 30 days | |
| Aripiprazole 10 mg Tab (Q3) | AMRITSAR | 3,300 | 30 days | - |
| Aripiprazole 15 mg Tab (Q3) | AMRITSAR | 1,500 | 30 days | |
| Beclometasone (0.025% w/v) + Clotrimazole (1% w/v) lotion 15 m (Q3) | AMRITSAR | 1,500 | 30 days | |
| BECLOMETHASONE DIPROPIONATE 0.05% LOTION (Q3) | AMRITSAR | 300 | 30 days | |
| CARBIDOPA 10 MG+ LEVODOPA 100 MG CR TAB (Q3) | AMRITSAR | 7,800 | 30 days | |
| CARBIDOPA 18.75+ LEVODOPA 75 MG+ ENTACAPONE 200 MG TAB (Q3) | AMRITSAR | 6,000 | 30 days | |
| CARBIDOPA 25 MG+ LEVODOPA 100 MG CR TAB (Q3) | AMRITSAR | 12,900 | 30 days | |
| Chlordiazepoxide 10mg Tab (Q3) | AMRITSAR | 31,500 | 30 days | - |
| CLOBAZAM 10 MG TAB (Q3) | AMRITSAR | 9,000 | 30 days | |
| CLOBETASOL+ NEOMYCIN (PROPYGENTA) CREAM (Q3) | AMRITSAR | 600 | 30 days | |
| Danazol 200 mg Tab (Q3) | AMRITSAR | 600 | 30 days | |
| DANAZOL 50MG TAB (Q3) | AMRITSAR | 300 | 30 days | |
| Dorzolamide 2% w/v+ Timolol 0.5% w/v E/D (Q3) | AMRITSAR | 360 | 30 days | |
| E/D Brinzolamide 1% (Q3) | AMRITSAR | 210 | 30 days |
Exempted
16 May 2024
25 Apr 2024
16 May 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_6306029.pdf
GEM_BID
re-28_2024-04-11-11-54-37_8c1cfb03b4fcd681e3de73cb8265c93b.pdf
SPECIFICATION
re-28_2024-04-11-11-54-58_1e990284c09578d9e83c9895f2ec64b9.pdf
SPECIFICATION
re-28_2024-04-11-11-55-22_01a2be3232bb1c594d73503ef4ffbe31.pdf
SPECIFICATION
re-28_2024-04-11-11-55-43_aaa44bf595f7d088fd654b175a7bac4d.pdf
SPECIFICATION
re-28_2024-04-11-11-56-04_5d920442de9daf4a1bb7e0ce556ad411.pdf
SPECIFICATION
re-28_2024-04-11-11-57-34_9c9b9ccacbdd3395eae34832a5e2fa54.pdf
SPECIFICATION
re-28_2024-04-11-11-58-04_ab81b8386df7a167d281ee2a00c58508.pdf
SPECIFICATION
re-28_2024-04-11-11-58-28_0452bf423b7e0632a6a5e097c3951f31.pdf
SPECIFICATION
re-28_2024-04-11-11-58-48_983547f666edd89a161d84b9cd71c507.pdf
SPECIFICATION
re-28_2024-04-11-11-59-08_9f664e002106b8d36ff7a914440f8de7.pdf
SPECIFICATION
re-28_2024-04-11-12-05-28_dd502bec4f8fc16ab3900f29a6080414.pdf
SPECIFICATION
re-28_2024-04-11-12-05-56_0dc5d74a3ec3e6734aa8a4c9187e3447.pdf
SPECIFICATION
re-28_2024-04-11-12-06-17_d3474c3331d48d6b3364325efda51ec5.pdf
SPECIFICATION
re-28_2024-04-11-12-06-45_5672257c595ccd3cfc2d0c2f45c92d86.pdf
SPECIFICATION
re-28_2024-04-11-12-07-07_0af032eeb6de4c4d9c9a01c167af55eb.pdf
SPECIFICATION
re-28_2024-04-11-12-07-30_8d0977958b4ecf2d7a526c1a2c09ec88.pdf
SPECIFICATION
re-28_2024-04-11-12-08-29_d41813d5c580ce3619d8f485289d9fbb.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .